Andrew Harkin, Ph.D. - Publications

Affiliations: 
Pharmacy Trinity College - Dublin 
Area:
neuropharmacology, drugs of abuse, psychiatric drugs

79 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Gormley S, Rouine J, McIntosh A, Kerskens C, Harkin A. Glial fibrillary acidic protein (GFAP) immunoreactivity correlates with cortical perfusion parameters determined by bolus tracking arterial spin labelling (bt-ASL) magnetic resonance (MR) imaging in the Wistar Kyoto rat. Physiology & Behavior. PMID 27068181 DOI: 10.1016/j.physbeh.2016.04.007  1
2016 Ryan KM, Griffin ÉW, Ryan KJ, Tanveer R, Vanattou-Saifoudine N, McNamee EN, Fallon E, Heffernan S, Harkin A, Connor TJ. Clenbuterol activates the central IL-1 system via the β2-adrenoceptor without provoking inflammatory response related behaviours in rats. Brain, Behavior, and Immunity. PMID 26928198 DOI: 10.1016/j.bbi.2016.02.023  1
2015 O'Farrell K, Harkin A. Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders. Neuropharmacology. PMID 26690895 DOI: 10.1016/j.neuropharm.2015.12.004  1
2015 Buckley N, Boyle D, McArt D, Irwin G, Harkin D, Lioe T, McQuaid S, James JA, Maxwell P, Hamilton P, Mullan PB, Salto-Tellez M. Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention. Oncotarget. PMID 26657114 DOI: 10.18632/oncotarget.6525  0.4
2015 Morgese MG, Colaianna M, Mhillaj E, Zotti M, Schiavone S, D'Antonio P, Harkin A, Gigliucci V, Campolongo P, Trezza V, De Stradis A, Tucci P, Cuomo V, Trabace L. Soluble beta amyloid evokes alteration in brain norepinephrine levels: role of nitric oxide and interleukin-1. Frontiers in Neuroscience. 9: 428. PMID 26594145 DOI: 10.3389/fnins.2015.00428  1
2015 Doucet MV, O'Toole E, Connor T, Harkin A. Small-molecule inhibitors at the PSD-95/nNOS interface protect against glutamate-induced neuronal atrophy in primary cortical neurons. Neuroscience. 301: 421-38. PMID 26071957 DOI: 10.1016/j.neuroscience.2015.06.004  1
2015 Rouine J, Kelly ME, Jennings-Murphy C, Duffy P, Gorman I, Gormley S, Kerskens CM, Harkin A. Investigation of the mechanisms mediating MDMA "Ecstasy"-induced increases in cerebro-cortical perfusion determined by btASL MRI. Psychopharmacology. 232: 1501-13. PMID 25366875 DOI: 10.1007/s00213-014-3790-0  1
2014 Harkin A. Muscling in on depression. The New England Journal of Medicine. 371: 2333-4. PMID 25494274 DOI: 10.1056/NEJMcibr1411568  1
2014 Frodl T, Carballedo A, Frey EM, O'Keane V, Skokauskas N, Morris D, Gill M, Hughes MM, Harkin A, Connor T. Expression of glucocorticoid inducible genes is associated with reductions in cornu ammonis and dentate gyrus volumes in patients with major depressive disorder. Development and Psychopathology. 26: 1209-17. PMID 25422956 DOI: 10.1017/S0954579414000972  1
2014 Gigliucci V, Gormley S, Gibney S, Rouine J, Kerskens C, Connor TJ, Harkin A. Characterisation of the antidepressant properties of nitric oxide synthase inhibitors in the olfactory bulbectomised rat model of depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1349-61. PMID 24931298 DOI: 10.1016/j.euroneuro.2014.05.003  1
2014 McManus C, Loan W, Lee B, Blair P, Harkin D. Late aneurysm rupture after delayed secondary open conversion with partial explantation for failed endovascular repair. Journal of Vascular Surgery. PMID 24865785 DOI: 10.1016/j.jvs.2014.04.054  0.4
2014 O'Donovan S, Dalton V, Harkin A, McLoughlin DM. Effects of brief pulse and ultrabrief pulse electroconvulsive stimulation on rodent brain and behaviour in the corticosterone model of depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1477-86. PMID 24607259 DOI: 10.1017/S1461145714000200  1
2014 Gibney SM, Fagan EM, Waldron AM, O'Byrne J, Connor TJ, Harkin A. Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 917-28. PMID 24472498 DOI: 10.1017/S1461145713001673  1
2014 Day JS, O'Neill E, Cawley C, Aretz NK, Kilroy D, Gibney SM, Harkin A, Connor TJ. Noradrenaline acting on astrocytic β₂-adrenoceptors induces neurite outgrowth in primary cortical neurons. Neuropharmacology. 77: 234-48. PMID 24126345 DOI: 10.1016/j.neuropharm.2013.09.027  1
2014 Connor TJ, Harkin A. Inflammation in the Pathogenesis of Depression Neuroinflammation and Cns Disorders. 261-288. DOI: 10.1002/9781118406557.ch11  1
2013 Pertl MM, Hevey D, Boyle NT, Hughes MM, Collier S, O'Dwyer AM, Harkin A, Kennedy MJ, Connor TJ. C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy. Brain, Behavior, and Immunity. 34: 108-19. PMID 23928287 DOI: 10.1016/j.bbi.2013.07.177  1
2013 Ryan KJ, Griffin É, Yssel JD, Ryan KM, McNamee EN, Harkin A, Connor TJ. Stimulation of central β2-adrenoceptors suppresses NFκB activity in rat brain: a role for IκB. Neurochemistry International. 63: 368-78. PMID 23896303 DOI: 10.1016/j.neuint.2013.07.006  1
2013 Rouine J, Gobbo OL, Campbell M, Gigliucci V, Ogden I, McHugh Smith K, Duffy P, Behan B, Byrne D, Kelly ME, Blau CW, Kerskens CM, Harkin A. MDMA 'ecstasy' increases cerebral cortical perfusion determined by bolus-tracking arterial spin labelling (btASL) MRI. British Journal of Pharmacology. 169: 974-87. PMID 23517012 DOI: 10.1111/bph.12178  1
2013 Gigliucci V, O'Dowd G, Casey S, Egan D, Gibney S, Harkin A. Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism. Psychopharmacology. 228: 157-66. PMID 23455595 DOI: 10.1007/s00213-013-3024-x  1
2013 Doucet MV, Levine H, Dev KK, Harkin A. Small-molecule inhibitors at the PSD-95/nNOS interface have antidepressant-like properties in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1575-84. PMID 23446451 DOI: 10.1038/npp.2013.57  1
2013 Gibney SM, McGuinness B, Prendergast C, Harkin A, Connor TJ. Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression. Brain, Behavior, and Immunity. 28: 170-81. PMID 23201589 DOI: 10.1016/j.bbi.2012.11.010  1
2012 Beumer W, Gibney SM, Drexhage RC, Pont-Lezica L, Doorduin J, Klein HC, Steiner J, Connor TJ, Harkin A, Versnel MA, Drexhage HA. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. Journal of Leukocyte Biology. 92: 959-75. PMID 22875882 DOI: 10.1189/jlb.0212100  1
2012 Hughes MM, Carballedo A, McLoughlin DM, Amico F, Harkin A, Frodl T, Connor TJ. Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation. Brain, Behavior, and Immunity. 26: 979-87. PMID 22683764 DOI: 10.1016/j.bbi.2012.05.010  1
2012 Vanattou-Saïfoudine N, McNamara R, Harkin A. Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediators. British Journal of Pharmacology. 167: 946-59. PMID 22671762 DOI: 10.1111/j.1476-5381.2012.02065.x  1
2012 Doucet MV, Harkin A, Dev KK. The PSD-95/nNOS complex: new drugs for depression? Pharmacology & Therapeutics. 133: 218-29. PMID 22133842 DOI: 10.1016/j.pharmthera.2011.11.005  1
2012 Vanattou-Saïfoudine N, Behan B, Harkin A. Dopamine D1 receptor-mediated intracellular responses in the hypothalamus after co-administration of caffeine with MDMA. Basic & Clinical Pharmacology & Toxicology. 110: 283-9. PMID 21967278 DOI: 10.1111/j.1742-7843.2011.00805.x  1
2011 Vanattou-Saïfoudine N, Gossen A, Harkin A. A role for adenosine A1 receptor blockade in the ability of caffeine to promote MDMA "ecstasy"-induced striatal dopamine release European Journal of Pharmacology. 650: 220-228. PMID 20951694 DOI: 10.1016/j.ejphar.2010.10.012  1
2010 Gleeson LC, Ryan KJ, Griffin EW, Connor TJ, Harkin A. The β2-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity. Brain, Behavior, and Immunity. 24: 1354-61. PMID 20599496 DOI: 10.1016/j.bbi.2010.06.015  1
2010 Vanattou-Saïfoudine N, McNamara R, Harkin A. Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats British Journal of Pharmacology. 160: 860-877. PMID 20590585 DOI: 10.1111/j.1476-5381.2010.00660.x  1
2010 Vanattou-Saïfoudine N, McNamara R, Harkin A. Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy') Psychopharmacology. 211: 15-25. PMID 20437223 DOI: 10.1007/s00213-010-1864-1  1
2010 McNamee EN, Griffin EW, Ryan KM, Ryan KJ, Heffernan S, Harkin A, Connor TJ. Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex. Neuropharmacology. 59: 37-48. PMID 20361987 DOI: 10.1016/j.neuropharm.2010.03.014  1
2010 McNamee EN, Ryan KM, Griffin EW, González-Reyes RE, Ryan KJ, Harkin A, Connor TJ. Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration. Brain, Behavior, and Immunity. 24: 660-71. PMID 20193756 DOI: 10.1016/j.bbi.2010.02.005  1
2010 O'Sullivan JB, Ryan KM, Harkin A, Connor TJ. Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge. Journal of Neuroimmunology. 220: 34-42. PMID 20061033 DOI: 10.1016/j.jneuroim.2009.12.007  1
2010 Gigliucci V, Buckley KN, Nunan J, O'Shea K, Harkin A. A role for serotonin in the antidepressant activity of NG-Nitro-L-arginine, in the rat forced swimming test. Pharmacology, Biochemistry, and Behavior. 94: 524-33. PMID 19945477 DOI: 10.1016/j.pbb.2009.11.007  1
2009 O'Sullivan JB, Ryan KM, Curtin NM, Harkin A, Connor TJ. Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 687-99. PMID 19046481 DOI: 10.1017/S146114570800967X  1
2008 Durkin S, Prendergast A, Harkin A. Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32: 1894-1901. PMID 18824064 DOI: 10.1016/j.pnpbp.2008.09.008  1
2008 Roche M, Shanahan E, Harkin A, Kelly JP. Trans-species assessment of antidepressant activity in a rodent model of depression. Pharmacological Reports : Pr. 60: 404-8. PMID 18622066  1
2008 Connor TJ, Starr N, O'Sullivan JB, Harkin A. Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma? Neuroscience Letters. 441: 29-34. PMID 18584961 DOI: 10.1016/j.neulet.2008.06.007  1
2007 Garland MR, Hallahan B, McNamara M, Carney PA, Grimes H, Hibbeln JR, Harkin A, Conroy RM. Lipids and essential fatty acids in patients presenting with self-harm. The British Journal of Psychiatry : the Journal of Mental Science. 190: 112-7. PMID 17267926 DOI: 10.1192/bjp.bp.105.019562  1
2007 McNamara R, Maginn M, Harkin A. Caffeine induces a profound and persistent tachycardia in response to MDMA ("Ecstasy") administration European Journal of Pharmacology. 555: 194-198. PMID 17126829 DOI: 10.1016/j.ejphar.2006.10.063  1
2007 Roche M, Harkin A, Kelly JP. Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 1312-20. PMID 17119540 DOI: 10.1038/sj.npp.1301253  1
2006 McNamara R, Kerans A, O'Neill B, Harkin A. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love") Neuropharmacology. 50: 69-80. PMID 16188283 DOI: 10.1016/j.neuropharm.2005.08.006  1
2005 Connor TJ, Brewer C, Kelly JP, Harkin A. Acute stress suppresses pro-inflammatory cytokines TNF-alpha and IL-1 beta independent of a catecholamine-driven increase in IL-10 production. Journal of Neuroimmunology. 159: 119-28. PMID 15652410 DOI: 10.1016/j.jneuroim.2004.10.016  1
2005 Zueger M, Urani A, Chourbaji S, Zacher C, Roche M, Harkin A, Gass P. Olfactory bulbectomy in mice induces alterations in exploratory behavior Neuroscience Letters. 374: 142-146. PMID 15644281 DOI: 10.1016/j.neulet.2004.10.040  1
2005 Connor TJ, Harkin A, Kelly JP. Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-alpha independent of a beta-adrenoceptor-mediated increase in interleukin-10. The Journal of Pharmacology and Experimental Therapeutics. 312: 134-43. PMID 15331655 DOI: 10.1124/jpet.104.073023  1
2004 Connole L, Harkin A, Maginn M. Adenosine A1 receptor blockade mimics caffeine's attenuation of ethanol-induced motor incoordination Basic and Clinical Pharmacology and Toxicology. 95: 299-304. PMID 15569276 DOI: 10.1111/j.1742-7843.2004.pto950509.x  1
2004 Harkin A, Connor TJ, Burns MP, Kelly JP. Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 14: 274-81. PMID 15163436 DOI: 10.1016/j.euroneuro.2003.08.010  1
2003 Harkin AJ, O'Donnell JM, Kelly JP. A combined and comparative study of physiologic and behavioral parameters in a systemic toxicity test. Contemporary Topics in Laboratory Animal Science / American Association For Laboratory Animal Science. 42: 31-8. PMID 19757623  1
2003 Harkin A, Hynes MJ, Masterson E, Kelly JP, O'Donnell JM, Connor TJ. A toxicokinetic study of nickel-induced immunosuppression in rats. Immunopharmacology and Immunotoxicology. 25: 655-70. PMID 14686805 DOI: 10.1081/IPH-120026448  1
2003 Harkin A, Shanahan E, Kelly JP, Connor TJ. Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine. The European Journal of Neuroscience. 18: 1021-7. PMID 12925028 DOI: 10.1046/j.1460-9568.2003.02802.x  1
2003 Harkin A, Connor TJ, Walsh M, St John N, Kelly JP. Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacology. 44: 616-23. PMID 12668047 DOI: 10.1016/S0028-3908(03)00030-3  1
2003 Harkin A, Kelly JP, Leonard BE. A review of the relevance and validity of olfactory bulbectomy as a model of depression Clinical Neuroscience Research. 3: 253-262. DOI: 10.1016/S1566-2772(03)00087-2  1
2002 Harkin A, O'Donnell JM, Kelly JP. A study of VitalView for behavioural and physiological monitoring in laboratory rats. Physiology & Behavior. 77: 65-77. PMID 12213503 DOI: 10.1016/S0031-9384(02)00810-7  1
2002 Harkin A, Houlihan DD, Kelly JP. Reduction in preference for saccharin by repeated unpredictable stress in mice and its prevention by imipramine. Journal of Psychopharmacology (Oxford, England). 16: 115-23. PMID 12095069  1
2002 Harkin A, Connor TJ, O'Donnell JM, Kelly JP. Physiological and behavioral responses to stress: what does a rat find stressful? Lab Animal. 31: 42-50. PMID 11927961 DOI: 10.1038/5000150  1
2001 Harkin A, Connor TJ, Mulrooney J, Kelly JP, Leonard BE. Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats. Life Sciences. 68: 1367-82. PMID 11388689 DOI: 10.1016/S0024-3205(00)01039-0  1
2001 Connor TJ, Dennedy MC, Harkin A, Kelly JP. Methylenedioxymethamphetamine-induced suppression of interleukin-1beta and tumour necrosis factor-alpha is not mediated by serotonin. European Journal of Pharmacology. 418: 147-52. PMID 11334877 DOI: 10.1016/S0014-2999(01)00928-1  1
2001 Harkin A, Morris K, Kelly JP, O'Donnell JM, Leonard BE. Modulation of MK-801-induced behaviour by noradrenergic agents in mice. Psychopharmacology. 154: 177-88. PMID 11314680 DOI: 10.1007/s002130000630  1
2000 Harkin A, Nally R, Kelly JP, Leonard BE. Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta1-adrenergic receptors in an animal model of depression. Journal of Neural Transmission (Vienna, Austria : 1996). 107: 1213-27. PMID 11129111 DOI: 10.1007/s007020070035  1
2000 Kelliher P, Connor TJ, Harkin A, Sanchez C, Kelly JP, Leonard BE. Varying responses to the rat forced-swim test under diurnal and nocturnal conditions. Physiology & Behavior. 69: 531-9. PMID 10913793 DOI: 10.1016/S0031-9384(00)00213-4  1
2000 Harkin A, Nowak G, Paul IA. Corrigendum to: "Noradrenergic lesion antagonizes desipramine-induced adaptation of NMDA receptors" European Journal of Pharmacology. 397: 399. PMID 10844140 DOI: 10.1007/BF02971991  1
2000 Connor TJ, Kelliher P, Shen Y, Harkin A, Kelly JP, Leonard BE. Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test. Pharmacology, Biochemistry, and Behavior. 65: 591-7. PMID 10764911 DOI: 10.1016/S0091-3057(99)00192-6  1
2000 Cryan JF, Harkin A, Naughton M, Kelly JP, Leonard BE. Characterization of D-fenfluramine-induced hypothermia: evidence for multiple sites of action. European Journal of Pharmacology. 390: 275-85. PMID 10708734 DOI: 10.1016/S0014-2999(00)00012-1  1
2000 Harkin A, Nowak G, Paul IA. Noradrenergic lesion antagonizes desipramine-induced adaptation of NMDA receptors. European Journal of Pharmacology. 389: 187-92. PMID 10688983 DOI: 10.1016/S0014-2999(99)00923-1  1
2000 Harkin A, Kelly JP, Frawley J, O'Donnell JM, Leonard BE. Test conditions influence the response to a drug challenge in rodents. Pharmacology, Biochemistry, and Behavior. 65: 389-98. PMID 10683478 DOI: 10.1016/S0091-3057(99)00210-5  1
2000 Connor TJ, Harkin A, Kelly JP, Leonard BE. Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment. Neuroimmunomodulation. 7: 27-35. PMID 10601816  1
1999 Connor TJ, Kelliher P, Harkin A, Kelly JP, Leonard BE. Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat. European Journal of Pharmacology. 379: 125-33. PMID 10497898 DOI: 10.1016/S0014-2999(99)00492-6  1
1999 Healy DG, Harkin A, Cryan JF, Kelly JP, Leonard BE. Metyrapone displays antidepressant-like properties in preclinical paradigms. Psychopharmacology. 145: 303-8. PMID 10494579 DOI: 10.1007/s002130051062  1
1999 Harkin AJ, Bruce KH, Craft B, Paul IA. Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. European Journal of Pharmacology. 372: 207-13. PMID 10395013 DOI: 10.1016/S0014-2999(99)00191-0  1
1999 Redmond AM, Harkin A, Kelly JP, Leonard BE. Effects of acute and chronic antidepressant administration on phencyclidine (PCP) induced locomotor hyperactivity. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 9: 165-70. PMID 10082243 DOI: 10.1016/S0924-977X(98)00023-6  1
1999 Harkin A, Kelly JP, McNamara M, Connor TJ, Dredge K, Redmond A, Leonard BE. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. European Journal of Pharmacology. 364: 123-32. PMID 9932714 DOI: 10.1016/S0014-2999(98)00838-3  1
1998 Faherty CJ, Harkin AJ, Leonard BE. The functional sensitisation of sigma receptors following chronic selective serotonin reuptake inhibitor treatment. European Journal of Pharmacology. 346: 15-21. PMID 9617747 DOI: 10.1016/S0014-2999(98)00041-7  1
1997 De Souza I, Kelly JP, Harkin AJ, Leonard BE. An appraisal of the pharmacological and toxicological effects of a single oral administration of 3,4-methylenedioxymethamphetamine (MDMA) in the rat. Pharmacology & Toxicology. 80: 207-10. PMID 9181598  1
1996 Sharma S, Sharma SC, Byrne PD, Lyons JB, Boylan JF, McShane AJ, Galligan ES, Sweetman SF, Clements BA, Lowe AS, McCormack KJM, Walsh DM, Baxter GD, Allen JM, Kelleher S, ... ... Harkin AJ, et al. Royal academy of medicine in Ireland section of biomedical sciences - Proceedings of winter meeting held in Trinity College Dublin, 1996 Irish Journal of Medical Science. 165: 304-314. DOI: 10.1007/BF02943100  1
1996 Mescall FM, Kane MT, Keyes WM, Quinlan LR, Hynes AC, Jordan FM, McGarvey C, Kelly JP, O'Donnell JM, Kelliher P, Cotton KD, Hollywood MA, Thornbury KD, McHale NG, Curran AK, ... ... Harkin AJ, et al. Royal academy of medicine in ireland section of biomedical sciences - Proceedings of summer meeting held june 1995 Irish Journal of Medical Science. 165: 224-238. DOI: 10.1007/BF02940256  1
1996 Harkin AJ, Kelly JP, Leonard BE. Single or repeated administration of selective serotonin reuptake inhibitors fail to modulate apomorphine-induced responses in the rat Journal of Serotonin Research. 3: 49-58.  1
1995 Harkin AJ, Kelly JP, Leonard BE. The comparative effects of long-term administration of sertraline, paroxetine, citalopram, fluoxetine and amitriptyline on monoamine content in rat brain Journal of Serotonin Research. 2: 181-190.  1
1892 Harkin A. On epistaxis and the hemorrhoidal flux: their pathogenic unity and identity of cure The Dublin Journal of Medical Science. 93: 461-476. DOI: 10.1007/BF02965734  1
1890 Harkin A. The vagus treatment of cholera, as exemplified in returns from the cholera hospitals of Malta, during the epidemic of 1887 The Dublin Journal of Medical Science. 89: 226-240. DOI: 10.1007/BF02953124  1
Show low-probability matches.